This study established a method that utilizes genetic code expansion to successfully incorporate lactyl-lysine (Klac) at specific sites of the human enolase-1 (hENO1) and superfolder GFP (sfGFP) in Escherichia coli and mammalian cells.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This study established a method that utilizes genetic code expansion to successfully incorporate lactyl-lysine (Klac) at specific sites of the human enolase-1 (hENO1) and superfolder GFP (sfGFP) in Escherichia coli and mammalian cells.
Lactylation is a recently discovered post-translational modification (PTM) with diverse biological functions. Since its initial identification in 2019 as a regulator of macrophage polarization, histone lactylation has emerged as a pivotal link connecting cellular metabolism to functional regulation. Biochemically, it involves the covalent transfer of a lactyl group to lysine residues, mediated either by lactyltransferases using lactyl-CoA as the acyl donor or by aminoacyl-tRNA synthetases (AARSs) via a lactyl-AMP intermediate. Through these mechanisms, intracellular lactate levels are directly coupled with protein modification and function. Lactylation mediates a range of critical cellular processes, from physiological functions such as gene regulation, DNA repair, metabolic reprogramming, and immune modulation to pathological processes such as tumor progression and metastasis. Despite the identification of numerous lactylation sites by proteomics, achieving site-specific lysine lactylation through mutagenesis remains challenging. To address this, we employ genetic code expansion technology, using a lactyl-lysine-specific aminoacyl-tRNA synthetase (KlacRS) and its cognate tRNA to precisely incorporate lactyl-lysine (Klac) at designated residues. This strategy enables the generation of homogeneously lactylated protein variants for direct functional studies. Here, we describe a streamlined protocol for site-specific protein lactylation, validated in both Escherichia coli (E. coli) and mammalian cells, using human enolase-1 (hENO1) and superfolder GFP (sfGFP) as model systems.
Lysine lactylation (Klac), originally identified on histones, has emerged as a key node linking aberrant tumor metabolism and epigenetic regulation1. The accumulation of lactate resulting from enhanced aerobic glycolysis in tumor cells provides a metabolic basis for lactylation, enabling lactate to act not merely as a metabolic byproduct but as a signaling molecule that directly modulates protein function. Increasing evidence indicates that lactylation broadly participates in tumor initiation and progression by coordinating cancer cell proliferation2,3,4
Access restricted. Please log in or start a trial to view this content.
1. Amber stop codon mutagenesis for genetic encoding of Lactyllysine into target gene
Access restricted. Please log in or start a trial to view this content.
We first evaluated the incorporation specificity of Klac into proteins in E. coli. The gene for human enolase 1 (hENO1) was engineered to contain an amber stop codon at residue K89 (hENO1-89TAG), and this construct was co-expressed with the orthogonal KlacRS and its cognate tRNA pair in E. coli. In the absence of 1 mM Klac supplementation, no full-length hENO1 was detected; by contrast, when 1 mM Klac was added to the growth media, full-length hENO1 containing Klac at position 89 (hENO1-89Klac).......
Access restricted. Please log in or start a trial to view this content.
Here, we describe a strategy for site-specific incorporation of Klac into proteins in both prokaryotic and eukaryotic cells. By introducing an amber stop codon at the desired position of the target gene and co-expressing it with the orthogonal KlacRS/tRNA pair in host cells, authentic lactyl lysine can be precisely incorporated into proteins in living cells, providing a powerful tool to probe lactylation-specific biology.
We demonstrated the feasibility of this workflow using the representativ.......
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interests to disclose.
This research was supported by the National Natural Science Foundation of China (22377058), the Interdisciplinary Funding for Synthetic Biology in Traditional Chinese Medicine by Nanjing University of Chinese Medicine, and the National High-Level Talent Special Support Programs (10,000 Talents Program) - Young Talents.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 6*his,His tag Recombinant monoclonal antibody | Proteintech | 84814-1-RR | A class of specific immunoglobulins targeting the 6×His tag (a short peptide composed of six consecutive histidine residues, HHHHHH) in recombinant proteins. |
| ACQUITY UPLC system | Waters | UltraPerformance Liquid Chromatography | |
| Anti-L-Lactyllysine Rabbit mAb | PTM Biolabs | PTM-1401RM | A class of specific immunoglobulins targeting L-Lactyl Lysine (Klac), a post-translational modification (PTM) of proteins. |
| ClonExpress II One Step Cloning Kit | Vazyme | C112 | Based on simple, rapid, and efficient DNA seamless cloning technology, insert fragments can be directionally cloned into any site of any vector. |
| CytoFlex flow cytometer | Beckmann Coulter | Flow cytometer with high-sensitivity detection and multi-color analysis capability | |
| DH10B | Biorabbit | EC005H-S | A type of competent cells for plasmid transformation, gene cloning, and blue-white screening. |
| DH5α | Vazyme | C502 | A type of competent cells for plasmid transformation, gene cloning, and blue-white screening. |
| EASY-nano LC 1200 system | Thermo Fisher Scientific | nano-liquid chromatography for separating high-sensitivity, high-resolution complex samples | |
| Orbitrap Eclipse Tribrid mass spectrometer | Thermo Fisher Scientific | a flagship high-end tribrid liquid chromatography-mass spectrometry (LC-MS) system | |
| Phanta Max Super-Fidelity DNA Polymerase | Vazyme | P505 | A high-fidelity single enzyme combining rapid amplification and fidelity |
| PolyJet | SignaGen | SL100688 | PolyJet DNA In Vitro Tranfection Reagent is formulated to be a powerful transfection Reagent that ensures effective and reproducible transfection with less cytotoxicity. |
Access restricted. Please log in or start a trial to view this content.